• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates.

作者信息

Levine Glenn N, Bates Eric R

机构信息

From Baylor College of Medicine and Michael E. DeBakey VA Medical Center, Houston, TX (G.N.L.); and University of Michigan, Ann Arbor (E.R.B.).

出版信息

Circulation. 2017 Jun 20;135(25):2451-2453. doi: 10.1161/CIRCULATIONAHA.117.028497.

DOI:10.1161/CIRCULATIONAHA.117.028497
PMID:28630264
Abstract
摘要

相似文献

1
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates.是时候结束关于双联抗血小板治疗短期与长期疗程的二元论争论了。
Circulation. 2017 Jun 20;135(25):2451-2453. doi: 10.1161/CIRCULATIONAHA.117.028497.
2
The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.与药物洗脱支架相关的支架内血栓形成问题以及双联抗血小板治疗的最佳持续时间。
Prev Cardiol. 2009 Spring;12(2):59-64. doi: 10.1111/j.1751-7141.2009.00031.x.
3
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.一名糖尿病患者发生的极晚期支架内血栓形成：呼吁进行终身双联抗血小板治疗。
Tenn Med. 2009 May;102(5):37-9.
4
Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention.急性冠状动脉综合征和经皮冠状动脉介入治疗患者抗血小板治疗的临床价值。
Biomark Med. 2011 Feb;5(1):9-30. doi: 10.2217/bmm.11.2.
5
[Antithrombocytic therapy and PCI. Duration of therapy after DCB/stents/scaffolds].[抗血小板治疗与经皮冠状动脉介入治疗。药物涂层球囊/支架/血管支架置入术后的治疗持续时间]
Herz. 2014 Nov;39(7):819-21. doi: 10.1007/s00059-014-4158-2.
6
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.载有佐他莫司的药物洗脱支架置入后双联抗血小板治疗 3 个月与 12 个月：OPTIMIZE 随机试验。
JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.
7
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.质子泵抑制剂对接受6个月或24个月双联抗血小板治疗患者临床结局的影响：来自评估支架诱导内膜增生后延长双联抗血小板治疗研究（PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial）的见解
Am Heart J. 2016 Apr;174:95-102. doi: 10.1016/j.ahj.2016.01.015. Epub 2016 Jan 25.
8
Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?冠状动脉支架置入术后双重抗血小板治疗的持续时间：缺血与出血之间的最佳平衡点在哪里？
Eur Heart J. 2015 May 21;36(20):1207-11. doi: 10.1093/eurheartj/ehv103. Epub 2015 Apr 2.
9
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.在 ATLAS-ACS 2 TIMI 51 研究中，接受利伐沙班治疗的急性冠脉综合征患者中支架血栓形成减少。
J Am Coll Cardiol. 2013 Jul 23;62(4):286-90. doi: 10.1016/j.jacc.2013.03.041. Epub 2013 Apr 16.
10
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.在TRITON-TIMI 38试验中，对接受经皮冠状动脉介入治疗和支架置入术的急性冠状动脉综合征患者进行强化口服抗血小板治疗以降低缺血事件（包括支架血栓形成）：一项随机试验的亚分析
Lancet. 2008 Apr 19;371(9621):1353-63. doi: 10.1016/S0140-6736(08)60422-5. Epub 2008 Apr 2.

引用本文的文献

1
Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI.支架内高缺血风险定义的 PCI 术后 12 个月内中断双联抗血小板治疗的血栓形成与出血事件比较。
J Interv Cardiol. 2022 Jan 13;2022:3895205. doi: 10.1155/2022/3895205. eCollection 2022.
2
Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel.老年急性冠状动脉综合征患者接受低剂量普拉格雷或氯吡格雷治疗的缺血和出血负担的时间过程。
J Am Heart Assoc. 2019 Jan 22;8(2):e010956. doi: 10.1161/JAHA.118.010956.
3
Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma.
冠状动脉疾病中的抗血小板治疗：一个棘手的难题。
J Clin Med. 2018 Apr 9;7(4):74. doi: 10.3390/jcm7040074.